Galectin‐1 production is elevated in hypertrophic scar

Small Leucine-Rich Proteoglycans in Skin Wound Healing

(2020) Xiaoxiao Pang et al.   Frontiers in Pharmacology

Dyspigmented Hypertrophic Scars: beyond Skin Color

(2019) Abdulnaser. Alkhalil et al.   Pigment Cell & Melanoma Research

Galectin-1 and Galectin-3 and Their Potential Binding Partners in the Dermal Thickening of Keloid Tissues

(2019) Enrique Arciniegas et al.   AMERICAN JOURNAL OF DERMATOPATHOLOGY

The Akt/FoxO/p27 Kip1 axis contributes to the anti‐proliferation of pentoxifylline in hypertrophic scars

(2019) Fangfang Yang et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Pregnancy Galectinology: Insights Into a Complex Network of Glycan Binding Proteins

(2019) Sandra M. Blois et al.   Frontiers in Immunology

MicroRNA-130a has pro-fibroproliferative potential in hypertrophic scar by targeting CYLD

(2019) Jian Zhang et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Reactive Oxygen Species Scavenging Potential Contributes to Hypertrophic Scar Formation

(2019) Bonnie C. Carney et al.   JOURNAL OF SURGICAL RESEARCH

Galectin-1 is a new fibrosis protein in type 1 and type 2 diabetes

(2018) Noor Al-Obaidi et al.   FASEB JOURNAL

Pigmentation Diathesis of Hypertrophic Scar: An Examination of Known Signaling Pathways to Elucidate the Molecular Pathophysiology of Injury-Related Dyschromia

(2018) Bonnie C Carney et al.   Journal of Burn Care & Research

Elastin Is Differentially Regulated by Pressure Therapy in a Porcine Model of Hypertrophic Scar

(2017) Bonnie C. Carney et al.   Journal of Burn Care & Research

Galectin-1: A Jack-of-All-Trades in the Resolution of Acute and Chronic Inflammation

(2017) Victoria Sundblad et al.   JOURNAL OF IMMUNOLOGY

Galectin-1 from conditioned medium of three-dimensional culture of adipose-derived stem cells accelerates migration and proliferation of human keratinocytes and fibroblasts

(2017) Min Ho Kim et al.   WOUND REPAIR AND REGENERATION

Endothelial dysfunction may play a key role in keloid and hypertrophic scar pathogenesis – Keloids and hypertrophic scars may be vascular disorders

(2016) Rei Ogawa et al.   MEDICAL HYPOTHESES

Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK/PI3K/AKT signaling

(2016) P-F Zhang et al.   Cell Death & Disease

Galectin-1 Accelerates Wound Healing by Regulating the Neuropilin-1/Smad3/NOX4 Pathway and ROS Production in Myofibroblasts

(2015) Yueh-Te Lin et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Galectin-1 has potential prognostic significance and is implicated in clear cell renal cell carcinoma progression through the HIF/mTOR signaling axis

(2014) N M A White et al.   BRITISH JOURNAL OF CANCER

Unraveling galectin-1 as a novel therapeutic target for cancer

(2013) Lucile Astorgues-Xerri et al.   CANCER TREATMENT REVIEWS

Analysis of the Human Tissue-specific Expression by Genome-wide Integration of Transcriptomics and Antibody-based Proteomics

(2013) Linn Fagerberg et al.   MOLECULAR & CELLULAR PROTEOMICS

Wound Repair and Regeneration

(2012) J.M. Reinke et al.   EUROPEAN SURGICAL RESEARCH

Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi’s sarcoma

(2012) Diego O. Croci et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress

(2011) Koichi Ito et al.   ANGIOGENESIS

When Galectins Recognize Glycans: From Biochemistry to Physiology and Back Again

(2011) Santiago Di Lella et al.   BIOCHEMISTRY

Human Galectins Induce Conversion of Dermal Fibroblasts into Myofibroblasts and Production of Extracellular Matrix: Potential Application in Tissue Engineering and Wound Repair

(2011) Barbora Dvořánková et al.   CELLS TISSUES ORGANS

The  -galactomannan Davanat binds galectin-1 at a site different from the conventional galectin carbohydrate binding domain

(2009) M. C Miller et al.   GLYCOBIOLOGY